Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial Free

• Abstracts
• Supplementary data

Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial Open Access

• Abstract
• Supplementary data

Long-Term Accuracy of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay and Its Application in Household Investigation Free

• Abstract
• Supplementary data

Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center Open Access

• Abstract

Interferon-γ Release Assay for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Response Free

• Abstract
• Supplementary data

Clinical Application and Limitations of Interferon-γ Release Assays for the Diagnosis of Latent Tuberculosis Infection Get access

• Abstract

Helicobacter pylori: Consensus and Controversy Get access

• Abstract

Azathioprine Hypersensitivity Mimicking Sepsis in a Patient with Crohn's Disease Get access